The hot news right now that the major media have not understood is the results of the Regional Biocontainment Laboratory, verifying that Brilacidin has dose-dependent inhibition of the COVID-19 virus.

The news that could come at any time is news about whatever next step they take -- whether it's to try it on human cells, or to get permission to start a human clinical trial, or something in between.